← All companies
IPSC
Century Therapeutics, Inc.
$1.98
-0.21 -9.59%
Key statistics
from XBRL data in SEC filingsMarket cap
$357M
Revenue (TTM)
$115M
Net income (TTM)
-$108M
EPS (TTM)
$-1.14
P/E ratio
—
Dividend yield
—
Free cash flow
-$105M
Cash
$51.0M
Total assets
$327M
Gross margin
—
52-week range
$0.44 – $3.04
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Jun 16, 2026
8-K
Amended charter or bylaws; Shareholder vote results
Jun 12, 2026
8-K
Other events
Jun 8, 2026
8-K
Results of operations (earnings release)
May 13, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Other events
Mar 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 12, 2026
10-K
Fiscal year ended 2025-12-31
Mar 12, 2026
8-K
Shareholder vote results; Other events
Jan 23, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Jan 8, 2026
8-K
Director or officer change
Dec 29, 2025
8-K
Regulation FD disclosure
Dec 12, 2025
8-K
Director or officer change; Regulation FD disclosure
Dec 9, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Nov 13, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Delisting notice or listing-rule failure
Aug 29, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Aug 14, 2025
8-K
Exit or disposal costs; Director or officer change
Jul 7, 2025
8-K
Shareholder vote results
Jun 16, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 15, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 19, 2025
10-K
Fiscal year ended 2024-12-31
Mar 19, 2025
8-K
Delisting notice or listing-rule failure
Feb 28, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 13, 2025
8-K
Terminated a material agreement
Dec 13, 2024
8-K
Results of operations (earnings release); Other events
Nov 5, 2024
10-Q
Quarter ended 2024-09-30
Nov 5, 2024
8-K
Director or officer change
Sep 26, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 8, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Other events
Jul 8, 2024
8-K/A
FORM 8-K/A
Jun 26, 2024
8-K
Shareholder vote results
Jun 24, 2024
8-K
Other events
Jun 3, 2024
8-K
Results of operations (earnings release)
May 9, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure
Apr 11, 2024